Targeting Tumor-intrinsic TAK1 triggers anti-tumor immunity and sensitizes pancreatic cancer to checkpoint blockade
Sapana Bansod, Timothy Hung-Po Chen, Vikas Somani, Lin Li, Suneeta Modekurty, Brett L. Knolhoff, Ryan Courtney Fields, Marianna B. Ruzinova, David G. DeNardo, Kian‐Huat Lim
This study identifies TAK1 as a therapeutic target in pancreatic cancer that enhances anti-tumor immunity and sensitizes tumors to checkpoint blockade.
bioRxiv · Oct 8, 2025 · PreprintCancer Biology